Web Results

www.researchgate.net/profile/Jerome_Schentag

Jerome J Schentag of University at Buffalo, The State University of New York, NY SUNY Buffalo. Read 405 publications, and contact Jerome J Schentag on ResearchGate, the professional network for scientists.

patents.justia.com/inventor/jerome-j-schentag

USPTO patent applications submitted by and patents granted to Jerome J. Schentag.

www.cplassociates.com/cv/schentag.pdf

Jerome J. Schentag. Position Titles: Professor of Pharmaceutical Sciences and Pharmacy, University at. Buffalo School of Pharmacy. Chief Executive Officer, CPL Associates LLC. Institution. Degree. Year. Field of Study. University of Nebraska at Omaha. Philadelphia College of Pharmacy & Science. B.S.. Pharm. D. 1973.

clinicaltrials.gov/ct2/show/NCT01724671

ClinicalTrials.gov Identifier: NCT01724671. Recruitment Status : Unknown. Verified November 2012 by Jerome Schentag, CPL Associates. Recruitment status was: Not yet recruiting. First Posted : November 12, 2012. Last Update Posted .... Principal Investigator: Jerome J Schentag, Pharm.D. State University at Buffalo ...

www.linkedin.com/in/jerome-schentag-9740069

View Jerome Schentag's profile on LinkedIn, the world's largest professional community. Jerome has 3 jobs listed on their profile. See the complete profile on LinkedIn and discover Jerome's connections and jobs at similar companies.

journals.sagepub.com/doi/abs/10.1177/106002808702101112

The limitations of the new drug development process, particularly in regard to the evaluation of drug safety, have resulted in a need for monitoring drug experience in the postmarketing period. Although a number of systems have evolved to perform postmarketing surveillance, each has important limitations, suggesting the ...

www.amjmed.com/article/0002-9343(91)90394-D/fulltext

5.Rylander, M and Hallander, HO. In vitro comparison of the activity of doxycyline, tetracycline, erythromycin and a new macrolide, CP-62,993 against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. (Suppl)Scand J Infect Dis. 1988; 53: 12–17. View in Article; |; Google Scholar. 6.Fiese, EF and ...

www.amjmed.com/article/S0002-9343(84)80074-1/fulltext

Cefmenoxime concentration/effect relationships were retrospectively explored for gram-negative bacteria isolated from 14 critical care patients treated for nosocomial pneumonia. The effects of cefmenoxime concentrations on in vitro growth kinetics of 21 isolated pathogens were studied using the Abbott MS-2 Research ...

slideplayer.com/slide/10366519

3 SARS Inf Control- Points n Spread from infected patients to health care workers is a primary concern n Clearly, at least some Viral elements pass through or around surgical masks, N95 Masks and HEPA filters n Personal Negative Pressure units extract live virus from air and lower the inoculum. With UV light concomitantly ...